In today’s rapidly transforming healthcare ecosystem, pharmaceutical and biotech organizations are being challenged to fundamentally rethink how they engage Healthcare Professionals (HCPs) and patients.
Traditional, activity-based engagement models built around reach, frequency, and volume no longer deliver meaningful return on investment.
Instead, the industry is moving toward AI-powered, data-driven, and value-centric engagement strategies that prioritise relevance, personalisation, and measurable patient impact.
“Reinventing HCP Engagement & Patient Impact for Better ROI” explores how AI-driven personalization, advanced analytics, and omnichannel orchestration are transforming commercial performance in pharma and biotech.
It presents a practical blueprint for scalable, compliant, and measurable engagement.
The report features insights from senior leaders across pharma, biotech, and health technology, including:
Romain Bonjean, CEO & Founder, RoseRx
Lorena Cabré, Global Digital & Content Strategy Lead / AI powered GTM Content Models, Roche
Tinkara Pavlovcic Kapitanovic, Global Marketing Operations Responsible - Global Commercial Development, Viatris
Alyssa Fenoglio, Founder & Strategic Advisor, The Human Algorithm Advisory
Ainara Luque, Global Scientific Communications Sr Mgr (Ex-US), Amgen
Marc Ryning, Senior Omnichannel Customer Engagement Manager - Region Europe & Canada, Novo Nordisk
Paulo Amaral, Go to Market Digital Innovation Lead, Takeda
Panos Papakonstantinou, Chief Digital Officer (CDIO), Arrow Resources
Vladimir Nimec, Head of Applied AI Solutions, Daiichi-Sankyo
Humberto Fonseca, Director of Global Medical Engagement, Ferring Pharmaceuticals
Bassem Shaweer, Head of Global Digital Business, Fidia Pharma
Download the full report to discover how AI-powered personalization can drive better ROI, stronger HCP relationships, and measurable patient impact.
